Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood–brain barrier

References

• PardridgeWMWhy is the global CNS pharmaceutical market so under-penetrated?Drug Discov Today2002715711790589
   PubMed Web of Science ®Google Scholar
• DanemanRThe blood–brain barrier in health and diseaseAnn Neurol201272564867223280789
   PubMed Web of Science ®Google Scholar
• OnNHChenFHintonMMillerDWAssessment of P-glycoprotein activity in the Blood–Brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniquesPharm Res201128102505251521598079
   PubMed Web of Science ®Google Scholar
• NicolazzoJAKatneniKDrug transport across the blood–brain barrier and the impact of breast cancer resistance protein (ABCG2)Curr Top Med Chem20099213014719200001
   PubMed Web of Science ®Google Scholar
• LöscherWPotschkaHBlood–brain barrier active efflux transporters: ATP-binding cassette gene familyNeuro Rx2005218698
   Google Scholar
• ZhangYSchuetzJDElmquistWFMillerDWPlasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cellsJ Pharmacol Exp Ther2004311244945515218051
   PubMed Web of Science ®Google Scholar
• PardridgeWMDrug targeting to the brainPharm Res20072491733174417554607
   PubMed Web of Science ®Google Scholar
• TietzeRLyerSDürrSAlexiouCNanoparticles for cancer therapy using magnetic forcesNanomedicine (Lond)20127344745722385201
   PubMed Web of Science ®Google Scholar
• ZhuLWangDWeiXMultifunctional pH-sensitive superpara-magnetic iron-oxide nanocomposites for targeted drug delivery and MR imagingJ Control Release2013169322823823485450
   PubMed Web of Science ®Google Scholar
• FanCHTingCYLinHJSPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug deliveryBiomaterials201334143706371523433776
   PubMed Web of Science ®Google Scholar
• LeeGYQianWPWangLTheranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancerACS Nano2013732078208923402593
   PubMed Web of Science ®Google Scholar
• XuCSunSNew forms of superparamagnetic nanoparticles for biomedical applicationsAdv Drug Deliv Rev201365573274323123295
   PubMed Web of Science ®Google Scholar
• KenzaouiBHBernasconiCCHofmannHJuillerat-JeanneretLEvaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cellsNanomedicine (Lond)201271395322191777
   PubMed Web of Science ®Google Scholar
• LeeMJVeisehOBhattaraiNRapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive methodPLoS One201053e953620209054
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• AlexiouCSchmidRJJurgonsRTargeting cancer cells: magnetic nanoparticles as drug carriersEur Biophys J200635544645016447039
   PubMed Web of Science ®Google Scholar
• OnNHMitchellRSavantSDBachmeierCJHatchGMMillerDWExamination of blood–brain barrier (BBB) integrity in a mouse brain tumor modelJ Neurooncol2013111213314323184143
   PubMed Web of Science ®Google Scholar
• SunZYathindranathVWordenMCharacterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture modelsInt J Nanomedicine2013896197023494517
   PubMed Web of Science ®Google Scholar
• YathindranathVRebbouhLMooreDFMillerDWvan LieropJHegmannTA versatile method for the reductive, one-pot synthesis of bare, hydrophilic and hydrophobic magnetite nanoparticlesAdv Funct Mater201121814571464
   Web of Science ®Google Scholar
• YathindranathVSunZWordenMOne-pot synthesis of iron oxide nanoparticles with functional silane shells: a versatile general precursor for conjugations and biomedical applicationsLangmuir20132934108501085823906380
   PubMed Web of Science ®Google Scholar
• HoffDSheikhLBhattacharyaSNayarSWebsterTJComparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood–brain barrierInt J Nanomedicine2013870371023426527
   PubMed Web of Science ®Google Scholar
• LiGSimonMJCancelLMPermeability of endothelial and astrocyte cocultures: in vitro blood–brain barrier models for drug delivery studiesAnn Biomed Eng20103882499251120361260
   PubMed Web of Science ®Google Scholar
• BerneBJPecoraRDynamic Light Scattering: With Applications to Chemistry, Biology, and PhysicsNew YorkDover Publications2000
   Google Scholar
• WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
   PubMed Web of Science ®Google Scholar
• PetriBBootzAKhalanskyAChemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactantsJ Control Release20071171515817150277
   PubMed Web of Science ®Google Scholar
• QiaoRJiaQHüwelSReceptor-mediated delivery of magnetic nanoparticles across the blood–brain barrierACS Nano2012643304331022443607
   PubMed Web of Science ®Google Scholar
• EtameABSmithCAChanWCRutkaJTDesign and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculatureNanomedicine201176992100021616168
   PubMed Web of Science ®Google Scholar
• BoockvarJATsiourisAJHofstetterCPSafety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood–brain barrier disruption for recurrent malignant glioma. Clinical articleJ Neurosurg2011114362463220964595
   PubMed Web of Science ®Google Scholar
• KiptooPSinagaECalcagnoAMEnhancement of drug absorption through the blood–brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptidesMol Pharm20118123924921128658
   PubMedGoogle Scholar
• OnNHSavantSToewsMMillerDWRapid and reversible enhancement of blood–brain barrier permeability using lysophosphatidic acidJ Cereb Blood Flow Metab201333121944195424045401
   PubMed Web of Science ®Google Scholar
• BorlonganCVGloverLESanbergPRHessDCPermeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapyCurr Pharm Des201218253670367622574981
   PubMed Web of Science ®Google Scholar
• HynynenKUltrasound for drug and gene delivery to the brainAdv Drug Deliv Rev200860101209121718486271
   PubMed Web of Science ®Google Scholar
• MuldoonLLNilaverGKrollRAComparison of intracerebral inoculation and osmotic blood–brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brainAm J Pathol19951476184018517495307
   PubMed Web of Science ®Google Scholar
• LiuHLHuaMYYangHWMagnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brainProc Natl Acad Sci U S A201010734152051521020696897
   PubMed Web of Science ®Google Scholar
• BurgessAHynynenKNoninvasive and targeted drug delivery to the brain using focused ultrasoundACS Chem Neurosci20134451952623379618
   PubMed Web of Science ®Google Scholar
• CarenzaEBarcelóVMoranchoAIn vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapiesNanomedicine201410122523423792330
   PubMed Web of Science ®Google Scholar
• KongSDLeeJRamachandranSMagnetic targeting of nanoparticles across the intact blood–brain barrierJ Control Release20121641495723063548
   PubMed Web of Science ®Google Scholar
• ChertokBDavidAEYangVCBrain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topographyJ Control Release2011155339339921763736
   PubMed Web of Science ®Google Scholar
• ChertokBMoffatBADavidAEIron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials200829448749617964647
   PubMed Web of Science ®Google Scholar
• ZhangJShinMCYangVCMagnetic targeting of novel heparinized iron oxide nanoparticles evaluated in a 9L-glioma mouse modelPharm Res201431357959224065589
   PubMed Web of Science ®Google Scholar
• DelgadoAVGonzález-CaballeroFHunterRJKoopalLKLyklemaJInternational Union of Pure and Applied Chemistry, Physical and Biophysical Chemistry Division IUPAC Technical ReportMeasurement and interpretation of electrokinetic phenomenaJ Colloid Interface Sci2007309219422417368660
   PubMed Web of Science ®Google Scholar
• LesniakASalvatiASantos-MartinezMJRadomskiMWDawsonKAÅbergCNanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiencyJ Am Chem Soc201313541438144423301582
   PubMed Web of Science ®Google Scholar
• Jedlovszky-HajdúABombelliFBMonopoliMPTombáczEDawsonKASurface coatings shape the protein corona of SPIONs with relevance to their application in vivoLangmuir20122842149831499123002920
   PubMed Web of Science ®Google Scholar
• RuhHKühlBBrenner-WeissGHopfCDiabatéSWeissCIdentification of serum proteins bound to industrial nanomaterialsToxicol Lett20122081415022001751
   PubMed Web of Science ®Google Scholar
• SafiMCourtoisJSeigneuretMConjeaudHBerretJFThe effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticlesBiomaterials201132359353936321911254
   PubMed Web of Science ®Google Scholar
• XinHShaXJiangXZhangWChenLFangXAnti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticlesBiomaterials201233328167817622889488
   PubMed Web of Science ®Google Scholar
• Yemis¸ciMGürsoy-ÖzdemirYCabanSBodurECapanYDalkaraTTransport of a caspase inhibitor across the blood–brain barrier by chitosan nanoparticlesMethods Enzymol201250825326922449930
   PubMed Web of Science ®Google Scholar
• LuWWanJSheZJiangXBrain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticleJ Control Release20071181385317240471
   PubMed Web of Science ®Google Scholar
• McNeeleyKMKarathanasisEAnnapragadaAVBellamkondaRVMasking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumorsBiomaterials20093023–243986399519427688
   PubMed Web of Science ®Google Scholar
• KeWShaoKHuangRGene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimerBiomaterials200930366976698519765819
   PubMed Web of Science ®Google Scholar
• ChenWZhanCGuBTargeted brain delivery of itraconazole via RVG29 anchored nanoparticlesJ Drug Target201119322823420540685
   PubMed Web of Science ®Google Scholar
• van RooyIMastrobattistaEStormGHenninkWESchiffelersRMComparison of five different targeting ligands to enhance accumulation of liposomes into the brainJ Control Release20111501303621087646
   PubMed Web of Science ®Google Scholar
• XieYYeLZhangXTransport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: in vitro and in vivo studiesJ Control Release20051051–210611915893839
   PubMed Web of Science ®Google Scholar
• GeorgievaJVKalicharanDCouraudPOSurface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitroMol Ther201119231832521045812
   PubMed Web of Science ®Google Scholar